Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
PHILADELPHIA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on...
Read moreDetails
Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human
Landmark cardiac xenotransplantation procedure conducted at University of Maryland Medical Center Tegoprubart, administered investigationally to prevent organ rejection post-transplant, targets...
Read moreDetailsNear Intelligence’s Board Grows Stronger with Key Appointments
Sherman Edmiston III and Richard J. Salute bring extensive technology, accounting, and business expertise to Near’s Board of DirectorsPASADENA, Calif.,...
Read moreDetailsClene Reports Significant Long-Term Survival Improvement From CNM-Au8 Treatment in HEALEY ALS Platform Trial Compared to PRO-ACT Historical Controls
Prolonged life with 49% decreased risk of death for participants in the HEALEY ALS Platform Trial treated with CNM-Au8® 30mg...
Read moreDetailsVoyager Therapeutics to Present at the Chardan Genetic Medicines Conference
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through...
Read moreDetailsHilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Read moreDetailsSEACOR HOLDINGS INC. ANNOUNCES SALE OF U.S. HARBOR TOWING ASSETS AND OPERATIONS
FORT LAUDERDALE, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- SEACOR Holdings Inc. (“SEACOR”) announced today the sale of its U.S....
Read moreDetailsNew Survey Results Showcase Dermatologists as the Primary Influencer for Patients’ Cosmetic Procedures and Skin Care Decisions
ating consumers’ motivation, preferred resources and influencers on their decisions about cosmetic procedures, provider type and skin care purchases. 2023...
Read moreDetailsCara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
Approval triggers $1.5 million milestone payment to CaraSTAMFORD, Conn., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a...
Read moreDetailsDEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Apellis Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that...
Read moreDetailsADVERTISEMENTS
